Home
Zero2IPO

Zero2IPO Market Share Analysis for March 2026

中国创业与投资行业引领者

Finance > Investing

Domainzero2ipo.com.cn

Year Founded1999

Employees201 - 500

Annual Revenue$200M - $500M

Zero2IPO

Zero2IPO (including company regionals)

zero2ipo.com.cn

See more website traffic and engagement information

Zero2IPO Revenue up to March 2026 is 200M - 500M

revenue generated by Zero2IPO top domains

Zero2IPO top domains revenue over 3 years

Revenue for Zero2IPO top domains

zero2ipo.com.cn200M - 500M

See more with Sales Intelligence

Total visits to Zero2IPO's top domains

Understand Zero2IPO market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

zero2ipo.com.cn1.7K

See more with Sales Intelligence

Avg. visit duration in Zero2IPO's top domains

Analyze Zero2IPO engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

zero2ipo.com.cn00:00:37

See more with Sales Intelligence

Avg. pageviews on Zero2IPO's top domains

See how Zero2IPO keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

zero2ipo.com.cn1.78

See more with Sales Intelligence

Zero2IPO top competitors by domain

Top similar sites in March 2026, ranked by their affinity

chinaventure.com.cnCompany NameChinaVentureEmployees51 - 200HQChina, BeijingAnnual revenue$15M - $25MTotal visits82.3KFinance > Investing

Top technologies used by Zero2IPO

These are the website technologies, by industry, used by Zero2IPO top domains

Payment & Currencies (21)

PayPal

Mobile (1)

Meta Viewport

Multilingual (1)

Multilingual Support

Widget (1)

General Captcha

News & Signals from Zero2IPO

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsZero2IPO Group invested into MicuRx Pharmaceuticals $43M in Series D on Aug 5th '20.August 5, 2020, MicuRx Pharmaceuticals, a Biotech focusing on discovery and development of novel antimicrobials, officially announced the close of nearly $43M series D financing, led by Huagai Capital, and with participation from Sinopharm-CICC and Zero2IPO Asset Management.

NewsZero2IPO Group invests into Zhuge.Chinese real estate information portal Zhuge.com has raised over RMB100 million ($14.10 million) in a Series C1 round of financing, led by Chinese investment firm Zero2IPO Group and Shanghai-based Beizeng Group.